Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Recombinant origin of the retrovirus XMRV.

Paprotka T, Delviks-Frankenberry KA, Cingöz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ Jr, Coffin JM, Pathak VK.

Science. 2011 Jul 1;333(6038):97-101. doi: 10.1126/science.1205292. Epub 2011 May 31.

2.

Characterization, mapping, and distribution of the two XMRV parental proviruses.

Cingöz O, Paprotka T, Delviks-Frankenberry KA, Wildt S, Hu WS, Pathak VK, Coffin JM.

J Virol. 2012 Jan;86(1):328-38. doi: 10.1128/JVI.06022-11. Epub 2011 Oct 26.

3.

Disease-associated XMRV sequences are consistent with laboratory contamination.

Hué S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, McLaren S, Pillay D, Futreal A, Garson JA, Pybus OG, Kellam P, Towers GJ.

Retrovirology. 2010 Dec 20;7(1):111. doi: 10.1186/1742-4690-7-111.

4.

Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences.

Oakes B, Tai AK, Cingöz O, Henefield MH, Levine S, Coffin JM, Huber BT.

Retrovirology. 2010 Dec 20;7:109. doi: 10.1186/1742-4690-7-109.

5.

Murine gammaretrovirus group G3 was not found in Swedish patients with myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia.

Elfaitouri A, Shao X, Mattsson Ulfstedt J, Muradrasoli S, Bölin Wiener A, Golbob S, Ohrmalm C, Matousek M, Zachrisson O, Gottfries CG, Blomberg J.

PLoS One. 2011;6(10):e24602. doi: 10.1371/journal.pone.0024602. Epub 2011 Oct 12.

6.

Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1.

Das Gupta J, Luk KC, Tang N, Gaughan C, Klein EA, Kandel ES, Hackett J Jr, Silverman RH.

PLoS One. 2012;7(5):e36072. doi: 10.1371/journal.pone.0036072. Epub 2012 May 16.

7.

Recombinant origin, contamination, and de-discovery of XMRV.

Delviks-Frankenberry K, Cingöz O, Coffin JM, Pathak VK.

Curr Opin Virol. 2012 Aug;2(4):499-507. doi: 10.1016/j.coviro.2012.06.009. Epub 2012 Jul 19. Review.

8.

In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.

Lee D, Das Gupta J, Gaughan C, Steffen I, Tang N, Luk KC, Qiu X, Urisman A, Fischer N, Molinaro R, Broz M, Schochetman G, Klein EA, Ganem D, Derisi JL, Simmons G, Hackett J Jr, Silverman RH, Chiu CY.

PLoS One. 2012;7(9):e44954. doi: 10.1371/journal.pone.0044954. Epub 2012 Sep 18.

9.

No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan.

Furuta RA, Miyazawa T, Sugiyama T, Kuratsune H, Ikeda Y, Sato E, Misawa N, Nakatomi Y, Sakuma R, Yasui K, Yamaguti K, Hirayama F.

Retrovirology. 2011 Mar 17;8:20. doi: 10.1186/1742-4690-8-20.

10.

XMRV and prostate cancer--a 'final' perspective.

Sfanos KS, Aloia AL, De Marzo AM, Rein A.

Nat Rev Urol. 2012 Jan 10;9(2):111-8. doi: 10.1038/nrurol.2011.225. Review.

11.

The left half of the XMRV retrovirus is present in an endogenous retrovirus of NIH/3T3 Swiss mouse cells.

Mendoza R, Vaughan AE, Miller AD.

J Virol. 2011 Sep;85(17):9247-8. doi: 10.1128/JVI.05137-11. Epub 2011 Jun 22.

12.

Multiple sources of contamination in samples from patients reported to have XMRV infection.

Kearney MF, Spindler J, Wiegand A, Shao W, Anderson EM, Maldarelli F, Ruscetti FW, Mellors JW, Hughes SH, Le Grice SF, Coffin JM.

PLoS One. 2012;7(2):e30889. doi: 10.1371/journal.pone.0030889. Epub 2012 Feb 20.

13.

Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.

Arredondo M, Hackett J Jr, de Bethencourt FR, Treviño A, Escudero D, Collado A, Qiu X, Swanson P, Soriano V, de Mendoza C.

AIDS Res Hum Retroviruses. 2012 Sep;28(9):1089-94. doi: 10.1089/AID.2011.0149. Epub 2012 Feb 21.

PMID:
22206583
14.

Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer.

Mikovits JA, Huang Y, Pfost MA, Lombardi VC, Bertolette DC, Hagen KS, Ruscetti FW.

AIDS Rev. 2010 Jul-Sep;12(3):149-52. Review.

PMID:
20842203
15.
16.

Generation of multiple replication-competent retroviruses through recombination between PreXMRV-1 and PreXMRV-2.

Delviks-Frankenberry K, Paprotka T, Cingöz O, Wildt S, Hu WS, Coffin JM, Pathak VK.

J Virol. 2013 Nov;87(21):11525-37. doi: 10.1128/JVI.01787-13. Epub 2013 Aug 21.

17.

Xenotropic murine leukemia virus-related virus proviral DNA not detected in blood samples donated in Japan.

Matsumoto C, Igarashi M, Furuta RA, Uchida S, Satake M, Tadokoro K.

Jpn J Infect Dis. 2012 Jul;65(4):334-6.

18.

An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV.

Sato E, Furuta RA, Miyazawa T.

Retrovirology. 2010 Dec 20;7:110. doi: 10.1186/1742-4690-7-110.

19.

Mouse DNA contamination in human tissue tested for XMRV.

Robinson MJ, Erlwein OW, Kaye S, Weber J, Cingoz O, Patel A, Walker MM, Kim WJ, Uiprasertkul M, Coffin JM, McClure MO.

Retrovirology. 2010 Dec 20;7:108. doi: 10.1186/1742-4690-7-108.

20.

Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.

Murgai M, Thomas J, Cherepanova O, Delviks-Frankenberry K, Deeble P, Pathak VK, Rekosh D, Owens G.

Retrovirology. 2013 Mar 27;10:34. doi: 10.1186/1742-4690-10-34.

Items per page

Supplemental Content

Write to the Help Desk